LENZ

LENZ THERAPEUTICS INC

3.500

+0.490+16.28%

After Hours: 3.510 +0.010 +0.29%19:30 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.000/3.010

TODAY RANGE3.000-3.510

VOL785.67K

MARKET CAP109.97M

52 WEEK RANGE2.800-32.13

AVG VOL (3M)886.37K

% TURNOVER2.32%

TURNOVER--

P/E (TTM)-0.7811

% RANGE16.94%

EPS(TTM)-4.4806

P/E(FORWARD)-1.2500

P/B0.5728

BVPS6.11

DIVIDEND--

P/S5.75

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP107.06M

SHARES OUTSTANDING31.42M

NEXT EARNINGS--

FREE FLOAT30.59M

LOT SIZE1

EX-DATE03/22/2024

News

Press Releases

Financial Reports

Profile

Dow Jones·1d ago
LENZ Therapeutics Price Target Cut to $9.00/Share From $10.00 by Citigroup
Dow Jones·1d ago
LENZ Therapeutics Is Maintained at Buy by Citigroup
TipRanks·1d ago
LENZ Therapeutics (LENZ) Receives a Buy from Citi
TipRanks·1d ago
Lenz Therapeutics price target lowered to $9 from $10 at Citi
NASDAQ·4d ago
LENZ (LENZ) Q3 2026 Earnings Call Transcript
TipRanks·10/30 16:55
Bank of America Securities Remains a Hold on LENZ Therapeutics (LENZ)
Dow Jones·10/30 11:50
LENZ Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·10/30 11:50
LENZ Therapeutics Price Target Cut to $16.00/Share From $38.00 by HC Wainwright & Co.
TipRanks·10/30 10:16
Lenz Therapeutics price target lowered to $16 from $38 at H.C. Wainwright
Seeking Alpha·10/29 19:44
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Dow Jones·10/29 17:35
LENZ Therapeutics Is Maintained at Buy by TD Cowen
Dow Jones·10/29 17:35
LENZ Therapeutics Price Target Cut to $45.00/Share From $50.00 by TD Cowen
TipRanks·10/29 13:10
Lenz Therapeutics price target lowered to $45 from $50 at TD Cowen
TipRanks·10/29 12:35
LENZ Therapeutics (LENZ) Gets a Buy from TD Cowen
Seeking Alpha·10/28 22:00
Here are the major earnings before the open Thursday

Same Industry

Name/Symbol

Change%

Price

LENZ

REGN

GRDX

BNTX

UTHR

VRTX

SIGA

MRNA

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

GILD

PRAH

ARCT

APVO

INCY

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.